Akebia Therapeutics, Inc. (AKBA) Stock Price History
Historical prices from 2014 to 2026
- 1M
- +45.4%
- 3M
- -1.4%
- YTD
- -12.3%
- 1Y
- -62.5%
- 3Y
- +10.1%
- 5Y
- -16.6%
Loading 10-year price history...
AKBA Historical Performance
AKBA Annual Returns
Year-by-year price performance · 2014–2026
- 2014 annual price return
- -56.4%
- 2015 annual price return
- +12.3%
- 2016 annual price return
- -17.1%
- 2017 annual price return
- +41.6%
- 2018 annual price return
- -63.1%
- 2019 annual price return
- +9.0%
- 2020 annual price return
- -55.8%
- 2021 annual price return
- -22.9%
- 2022 annual price return
- -76.4%
- 2023 annual price return
- +99.0%
- 2024 annual price return
- +49.6%
- 2025 annual price return
- -15.3%
- 2026 annual price return
- -15.5%
AKBA Stock Price Trajectory (2014–2026)
As of July 8, 2026, Akebia Therapeutics, Inc. (AKBA) trades at $1.36, representing a -62.5% return over the past year. The stock has delivered a -59.8% total return over five years (-16.6% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $31.00 on June 20, 2014. From this peak, AKBA has corrected -95.6%, currently trading 15% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers FOLD (+139.5% 1Y), PTGX (+182.4% 1Y), and CYCN (+12.6% 1Y), AKBA has underperformed the peer group average. Compare AKBA vs FOLD →
AKBA Historical Price Data · from 2014
Rows 1–50 of 3,093| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-07-07 | 1.30 | 1.39 | 1.29 | 1.36 | 5.74M | +4.62% |
| 2026-07-06 | 1.25 | 1.33 | 1.25 | 1.30 | 6.31M | +4.84% |
| 2026-07-02 | 1.22 | 1.24 | 1.16 | 1.24 | 4.17M | +2.48% |
| 2026-07-01 | 1.15 | 1.25 | 1.15 | 1.21 | 6.03M | +6.14% |
| 2026-06-30 | 1.28 | 1.29 | 1.11 | 1.14 | 6.83M | +2.70% |
| 2026-06-29 | 1.14 | 1.16 | 1.09 | 1.11 | 3.54M | -2.63% |
| 2026-06-26 | 1.04 | 1.14 | 1.03 | 1.14 | 0 | +9.62% |
| 2026-06-25 | 1.04 | 1.08 | 1.03 | 1.04 | 3.16M | -1.89% |
| 2026-06-24 | 1.10 | 1.13 | 1.05 | 1.06 | 3.74M | -3.64% |
| 2026-06-23 | 1.11 | 1.14 | 1.09 | 1.10 | 2.34M | +0.92% |
| 2026-06-22 | 1.08 | 1.14 | 1.07 | 1.09 | 5.03M | +1.87% |
| 2026-06-18 | 1.05 | 1.08 | 1.00 | 1.07 | 22.76M | +4.90% |
| 2026-06-17 | 0.99 | 1.05 | 0.98 | 1.02 | 3.95M | +3.66% |
| 2026-06-16 | 0.92 | 1.02 | 0.92 | 0.98 | 7.97M | +4.83% |
| 2026-06-15 | 0.93 | 0.94 | 0.90 | 0.94 | 5.49M | +1.54% |
| 2026-06-12 | 0.89 | 0.96 | 0.88 | 0.92 | 5.23M | +2.79% |
| 2026-06-11 | 0.86 | 0.93 | 0.84 | 0.90 | 16.64M | +3.04% |
| 2026-06-10 | 0.92 | 0.96 | 0.82 | 0.87 | 7.15M | -5.12% |
| 2026-06-09 | 0.95 | 0.96 | 0.90 | 0.92 | 2.04M | -1.67% |
| 2026-06-08 | 0.95 | 0.97 | 0.90 | 0.94 | 2.48M | +0.03% |
| 2026-06-05 | 0.97 | 0.99 | 0.93 | 0.94 | 1.84M | -3.61% |
| 2026-06-04 | 0.97 | 1.00 | 0.96 | 0.97 | 2.37M | +0.06% |
| 2026-06-03 | 0.94 | 0.97 | 0.92 | 0.97 | 4.55M | +3.56% |
| 2026-06-02 | 1.01 | 1.02 | 0.91 | 0.94 | 7.02M | -8.20% |
| 2026-06-01 | 1.02 | 1.04 | 1.00 | 1.02 | 2.75M | 0.00% |
| 2026-05-29 | 1.05 | 1.05 | 1.02 | 1.02 | 2.70M | -2.86% |
| 2026-05-28 | 1.04 | 1.07 | 1.01 | 1.05 | 2.93M | +1.94% |
| 2026-05-27 | 1.04 | 1.08 | 1.03 | 1.03 | 2.48M | -0.96% |
| 2026-05-26 | 1.02 | 1.08 | 1.02 | 1.04 | 2.96M | +1.96% |
| 2026-05-22 | 1.01 | 1.05 | 1.00 | 1.02 | 2.29M | 0.00% |
| 2026-05-21 | 1.00 | 1.07 | 0.99 | 1.02 | 5.53M | +0.99% |
| 2026-05-20 | 0.90 | 1.01 | 0.90 | 1.01 | 18.69M | +12.84% |
| 2026-05-19 | 1.00 | 1.00 | 0.88 | 0.90 | 15.38M | -11.38% |
| 2026-05-18 | 1.06 | 1.08 | 1.00 | 1.01 | 6.55M | -4.72% |
| 2026-05-15 | 1.14 | 1.14 | 1.06 | 1.06 | 4.78M | -6.19% |
| 2026-05-14 | 1.18 | 1.19 | 1.13 | 1.13 | 4.05M | -4.24% |
| 2026-05-13 | 1.18 | 1.20 | 1.16 | 1.18 | 3.66M | 0.00% |
| 2026-05-12 | 1.17 | 1.23 | 1.17 | 1.18 | 4.52M | +1.29% |
| 2026-05-11 | 1.15 | 1.23 | 1.14 | 1.17 | 4.51M | +0.43% |
| 2026-05-08 | 1.17 | 1.20 | 1.13 | 1.16 | 4.39M | -1.69% |
| 2026-05-07 | 1.15 | 1.23 | 1.13 | 1.18 | 11.70M | -20.27% |
| 2026-05-06 | 1.48 | 1.53 | 1.46 | 1.48 | 3.68M | +2.07% |
| 2026-05-05 | 1.53 | 1.53 | 1.43 | 1.45 | 2.15M | -3.33% |
| 2026-05-04 | 1.41 | 1.53 | 1.41 | 1.50 | 3.26M | +7.14% |
| 2026-05-01 | 1.40 | 1.44 | 1.38 | 1.40 | 2.52M | +1.45% |
| 2026-04-30 | 1.39 | 1.41 | 1.36 | 1.38 | 1.07M | +1.47% |
| 2026-04-29 | 1.41 | 1.41 | 1.35 | 1.36 | 2.18M | -4.23% |
| 2026-04-28 | 1.42 | 1.46 | 1.41 | 1.42 | 1.51M | 0.00% |
| 2026-04-27 | 1.43 | 1.51 | 1.42 | 1.42 | 2.66M | -0.70% |
| 2026-04-24 | 1.42 | 1.45 | 1.41 | 1.43 | 2.37M | 0.00% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10-year return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
AKBA — Frequently Asked Questions
Quick answers to the most common questions about buying AKBA stock.
How has AKBA stock performed recently?
AKBA declined -62.5% over the past year, below its 5-year annualized CAGR of -16.6%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is AKBA's all-time high price?
Akebia Therapeutics, Inc. reached $31.00 on 2014-06-20. The 52-week high is $4.08. Current 1-year return of -62.5% places the stock further from historical peaks.
Where can I download AKBA historical price data?
This page provides AKBA daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.